Printer Friendly

Browse Ophthalmic drugs topic

Dosage and administration subtopic

 

Articles

1-12 out of 12 article(s)
Title Author Type Date Words
Envisia Therapeutics Releases ENV515 (travoprost XR) Phase 2 Data Showing Nine-Month Duration Of Action After A Single Dose In Patients With Glaucoma. Oct 17, 2016 675
Traditional eye medication and pterygium occurrence in Limpopo Province. Anguria, P.; Ntuli, S.; Interewicz, B.; Carmichael, T. Report Aug 1, 2012 3126
InSite Vision Announces Positive Phase 2 PK Results for BromSite[TM] (ISV-303) for the Reduction of Pain and Inflammation After Cataract Surgery. Clinical report Oct 4, 2011 1390
Vitamins and eye drops: as the weather gets colder and the central heating goes on, patients are more aware of products to keep their eyes healthy. Robina Moss looks at the latest launches to target this opportunity. Moss, Robina Buyers guide Sep 30, 2011 371
Vitamin B2 Eye Drops and Low Dose Ultraviolet May Cure Keratoconus. Mar 29, 2011 397
Vitamin A Eye Drops for Dry Eyes. Gaby, Alan R. Brief article Jul 1, 2009 270
FDA panel backs new fluoroquinolone for conjunctivitis. MeChcatie, Elizabeth Jan 1, 2009 638
Meda: FDA Approves Azelastine Eye Drops Unit Dose. Jul 8, 2008 173
Othera Pharmaceuticals Announces First Patient Dosed with OT-551 Eye Drops in a Phase 2 Clinical Trial of Geographic Atrophy. Jun 11, 2007 651
Topical ocular drug delivery to inner ear disease and sinusitis. Amano, Shiro Nov 1, 2006 1291
Glaucoma; Treatment. Dec 15, 2005 3328
IOMED SHOWS SAFETY OF IONTOPHORESIS IN OPHTHALMIC APPLICATIONS. Jun 1, 2000 282

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters